150 related articles for article (PubMed ID: 15571777)
1. Real-Time, label-free monitoring of tumor antigen and serum antibody interactions.
Campagnolo C; Meyers KJ; Ryan T; Atkinson RC; Chen YT; Scanlan MJ; Ritter G; Old LJ; Batt CA
J Biochem Biophys Methods; 2004 Nov; 61(3):283-98. PubMed ID: 15571777
[TBL] [Abstract][Full Text] [Related]
2. Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.
Mischo A; Wadle A; Wätzig K; Jäger D; Stockert E; Santiago D; Ritter G; Regitz E; Jäger E; Knuth A; Old L; Pfreundschuh M; Renner C
Cancer Immun; 2003 Jun; 3():5. PubMed ID: 12828452
[TBL] [Abstract][Full Text] [Related]
3. Surface plasmon resonance and surface plasmon field-enhanced fluorescence spectroscopy for sensitive detection of tumor markers.
Arima Y; Teramura Y; Takiguchi H; Kawano K; Kotera H; Iwata H
Methods Mol Biol; 2009; 503():3-20. PubMed ID: 19151933
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.
Vaisocherová H; Faca VM; Taylor AD; Hanash S; Jiang S
Biosens Bioelectron; 2009 Mar; 24(7):2143-8. PubMed ID: 19157844
[TBL] [Abstract][Full Text] [Related]
5. Biomolecular interactions by Surface Plasmon Resonance technology.
Torreri P; Ceccarini M; Macioce P; Petrucci TC
Ann Ist Super Sanita; 2005; 41(4):437-41. PubMed ID: 16569911
[TBL] [Abstract][Full Text] [Related]
6. Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses.
Valmori D; Souleimanian NE; Hesdorffer CS; Ritter G; Old LJ; Ayyoub M
Clin Immunol; 2005 Oct; 117(1):24-30. PubMed ID: 15994128
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
Vaughan HA; Svobodova S; Macgregor D; Sturrock S; Jungbluth AA; Browning J; Davis ID; Parente P; Chen YT; Stockert E; St Clair F; Old LJ; Cebon J
Clin Cancer Res; 2004 Dec; 10(24):8396-404. PubMed ID: 15623618
[TBL] [Abstract][Full Text] [Related]
8. A new surface plasmon resonance sensor for high-throughput screening applications.
Piliarik M; Vaisocherová H; Homola J
Biosens Bioelectron; 2005 Apr; 20(10):2104-10. PubMed ID: 15741081
[TBL] [Abstract][Full Text] [Related]
9. A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients.
Ayyoub M; Souleimanian NE; Godefroy E; Scotto L; Hesdorffer CS; Old LJ; Valmori D
Clin Immunol; 2006; 118(2-3):188-94. PubMed ID: 16368270
[TBL] [Abstract][Full Text] [Related]
10. Multiplexed immunoassay for the rapid detection of anti-tumor-associated antigens antibodies.
Desmet C; Le Goff GC; Brès JC; Rigal D; Blum LJ; Marquette CA
Analyst; 2011 Jul; 136(14):2918-24. PubMed ID: 21666912
[TBL] [Abstract][Full Text] [Related]
11. Label-free antibody-antigen binding detection by optical sensor array based on surface-synthesized gold nanoparticles.
Olkhov RV; Shaw AM
Biosens Bioelectron; 2008 Mar; 23(8):1298-302. PubMed ID: 18207729
[TBL] [Abstract][Full Text] [Related]
12. Surface plasmon resonance biosensor for biomolecular interaction analysis based on spatial modulation phase detection.
Ding X; Liu F; Yu X
Methods Mol Biol; 2009; 503():21-35. PubMed ID: 19151934
[TBL] [Abstract][Full Text] [Related]
13. Surface plasmon resonance-based immunoassays.
Mullett WM; Lai EP; Yeung JM
Methods; 2000 Sep; 22(1):77-91. PubMed ID: 11020321
[TBL] [Abstract][Full Text] [Related]
14. Surface plasmon resonance biosensing.
Piliarik M; Vaisocherová H; Homola J
Methods Mol Biol; 2009; 503():65-88. PubMed ID: 19151937
[TBL] [Abstract][Full Text] [Related]
15. Label-free detection with the resonant mirror biosensor.
Zourob M; Elwary S; Fan X; Mohr S; Goddard NJ
Methods Mol Biol; 2009; 503():89-138. PubMed ID: 19151938
[TBL] [Abstract][Full Text] [Related]
16. A quantitative human monoclonal antibody immunoassay using anti-idiotypic antibody as a membrane antigen surrogate with surface-plasmon-resonance detection.
Wong RB; Lee AH; Rangan VS; Cheng KC
Biotechnol Appl Biochem; 2009 May; 53(Pt 1):51-61. PubMed ID: 18680480
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of weak affinity antibody antigen recognition with biomolecular interaction analysis.
Ohlson S; Strandh M; Nilshans H
J Mol Recognit; 1997; 10(3):135-8. PubMed ID: 9408829
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432.
Aoki M; Ueda S; Nishikawa H; Kitano S; Hirayama M; Ikeda H; Toyoda H; Tanaka K; Kanai M; Takabayashi A; Imai H; Shiraishi T; Sato E; Wada H; Nakayama E; Takei Y; Katayama N; Shiku H; Kageyama S
Vaccine; 2009 Nov; 27(49):6854-61. PubMed ID: 19761832
[TBL] [Abstract][Full Text] [Related]
19. Application of an antibody biochip for p53 detection and cancer diagnosis.
Askari M; Alarie JP; Moreno-Bondi M; Vo-Dinh T
Biotechnol Prog; 2001; 17(3):543-52. PubMed ID: 11386877
[TBL] [Abstract][Full Text] [Related]
20. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo.
Garcia Casado J; Janda J; Wei J; Chapatte L; Colombetti S; Alves P; Ritter G; Ayyoub M; Valmori D; Chen W; Lévy F
Eur J Immunol; 2008 Jul; 38(7):1867-76. PubMed ID: 18546142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
